MiR-210: Fine-tuning the hypoxic response

Mircea Ivan, Xin Huang

Research output: Chapter in Book/Report/Conference proceedingConference contribution


Hypoxia is a central component of the tumor microenvironment and represents a major source of therapeutic failure in cancer therapy. Recent work has provided a wealth of evidence that noncoding RNAs and, in particular, microRNAs, are significant members of the adaptive response to low oxygen in tumors. All published studies agree that miR-210 specifically is a robust target of hypoxia-inducible factors, and the induction of miR-210 is a consistent characteristic of the hypoxic response in normal and transformed cells. Overexpression of miR-210 is detected in most solid tumors and has been linked to adverse prognosis in patients with soft-tissue sarcoma, breast, head and neck, and pancreatic cancer. A wide variety of miR-210 targets have been identified, pointing to roles in the cell cycle, mitochondrial oxidative metabolism, angiogenesis, DNA damage response, and cell survival. Additional microRNAs seem to be modulated by low oxygen in a more tissue-specific fashion, adding another layer of complexity to the vast array of protein-coding genes regulated by hypoxia.

Original languageEnglish
Title of host publicationAdvances in Experimental Medicine and Biology
Number of pages23
StatePublished - 2014

Publication series

NameAdvances in Experimental Medicine and Biology
ISSN (Print)00652598

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Fingerprint Dive into the research topics of 'MiR-210: Fine-tuning the hypoxic response'. Together they form a unique fingerprint.

  • Cite this

    Ivan, M., & Huang, X. (2014). MiR-210: Fine-tuning the hypoxic response. In Advances in Experimental Medicine and Biology (Vol. 772, pp. 205-227). (Advances in Experimental Medicine and Biology; Vol. 772). https://doi.org/10.1007/978-1-4614-5915-6-10